Swath-ms technology

Show results for

Proteomics (213)
Unknown (86)
Metabolomics (4)

Organisms

Allexis (204)
Arabidopsis thaliana (204)
Callinectes sapidus (204)
Danio rerio (204)
Drosophila (204)
Drosophila melanogaster (204)
Ensifer adhaerens (204)
Entamoeba histolytica (204)
Escherichia coli (204)
Leishmania major strain Friedlin (204)
Listeria monocytogenes (204)
Medicago truncatula (204)
Methylohalobius crimeensis 10Ki (204)
Mus musculus (204)
Mycobacterium tuberculosis (204)
Oryza sativa Indica Group (204)
Physcomitrium patens (204)
Pseudomonas fluorescens WH6 (204)
Rattus norvegicus (204)
Saccharomyces cerevisiae (204)
Schizosaccharomyces pombe (204)
Schizosaccharomyces pombe 972h- (204)
Shigella (204)
Homo sapiens (2)
Escherichia coli (2)
Ctenopharyngodon idellus x Elopichthys bambusa (1)
Hypophthalmichthys molitrix (1)
Hypophthalmichthys nobilis (1)
Mus musculus (1)
Mylopharyngodon piceus (1)

Repository

pride (204)
iProX (4)
MassIVE (4)
MetaboLights (4)
jPOST (1)

Tissue

Cell culture (54)
Blood plasma (22)
Brain (14)
Epithelial cell (14)
Liver (14)
Kidney (9)
Blood serum (8)
Permanent cell line cell (8)
Heart (7)
Plant cell (7)
Blood (6)
Leaf (6)
Saliva (6)
Blood cell (5)
Embryo (5)
Lung (5)
Skin (5)
Stem cell (5)
Testis (5)
Urine (5)
Whole body (5)
Wound fluid (5)
Hepatocyte (4)
Macrophage (4)
Prostate adenocarcinoma cell (4)
Root (4)
Spleen (4)
Fibroblast (3)
HeLa cell (3)
Monocyte (3)

Disease

Disease free (9)
Wounds and Injuries (8)
Prostate adenocarcinoma (7)
Breast cancer (4)
Colon cancer (4)
COVID-19 (3)
Cervix carcinoma (3)
Acute leukemia (2)
Malignant neoplasm of ovary (2)
Parkinson's disease (2)
Acinetobacter infectious disease (1)
Anorexia nervosa (1)
Aortic valve stenosis (1)
Autism spectrum disorder (1)
Autoimmune vasculitis (1)
Brain cancer (1)
Cardiovascular system disease (1)
Chronic kidney disease (1)
Chronic myeloid leukemia (1)
Colorectal adenocarcinoma (1)
End stage renal disease (1)
Hepatocellular carcinoma (1)
Infertility (1)
Keratoconus (1)
Kidney cancer (1)
Long COVID (1)
Lung mixed small cell and squamous cell carcinoma (1)
Lymphoma (1)
Malaria (1)
Wiskott-Aldrich syndrome (1)

Technology Type

Mass Spectrometry (204)
SWATH MS (185)
Shotgun proteomics (49)
Data-independent acquisition (8)
Bottom-up proteomics (6)
Mass spectrometry (3)
Gel-based experiment (3)
Data-dependent acquisition (2)
Top-down proteomics (2)
Mass spectrometry assay (1)
Affinity purification coupled with mass spectrometry proteomics (1)
DiaPASEF (1)
SRM/MRM (1)

Instrument Platform

Liquid Chromatography MS - positive - reverse phase (4)
TripleTOF 5600 (3)
Liquid Chromatography MS - negative - reverse phase (2)
TripleTOF 6600 (1)

Publication Date

2023 (32)
2022 (31)
2021 (27)
2025 (23)
2020 (23)
2024 (22)
2018 (15)
2019 (14)
2026 (12)
2017 (7)
2016 (5)
2015 (4)

CHEBI ID

CHEBI:75095 (2)
CHEBI:193020 (1)
CHEBI:83555 (1)
CHEBI:193019 (1)
CHEBI:193018 (1)
CHEBI:193017 (1)
CHEBI:193015 (1)
CHEBI:71215 (1)
CHEBI:192337 (1)
CHEBI:193022 (1)
CHEBI:182413 (1)
CHEBI:21839 (1)
CHEBI:193021 (1)
CHEBI:41030 (1)
CHEBI:166563 (1)
CHEBI:182548 (1)
CHEBI:10429 (1)
CHEBI:4952 (1)
CHEBI:177050 (1)
CHEBI:26604 (1)
CHEBI:176179 (1)
CHEBI:28705 (1)
CHEBI:43295 (1)
CHEBI:139441 (1)
CHEBI:171846 (1)
CHEBI:182695 (1)
CHEBI:163396 (1)
CHEBI:93213 (1)
CHEBI:141436 (1)
CHEBI:144330 (1)

Metabolite Name

Gmelinol (1)
Proquinazid (1)
Alpha-guaiaconic acid (1)
6-Methoxyflavone (1)
Sinapic aldehyde (1)
D-Limonene (1)
N-(2,4-dimethylphenyl)formamide (1)
5-Flurocytosine (1)
1,3-Dimethyl-2-imidazolidinon (1)
1-Hexylamine (1)
Beta-Lapachone (1)
Evoxine (1)
Phloridzin (1)
Cyclopenin (1)
4-Piperidinecarboxamide (1)
Lenalidomide (1)
2-Phenylethylamine (1)
2-Quinolinecarboxylic acid (1)
Dimethyl-L-arginine (1)
Glu-Val-Phe (1)
P-Coumaraldehyde (1)
N1-acetylspermine (1)
2-Hydroxyquinoline (1)
Piperazine (1)
Zapotin (1)
Ile-Pro-Ile (1)
Delta-Undecalactone (1)
1-Naphthylamine (1)
Santonin (1)
Cadaverine (1)

Release Date

2020 (14)
2024 (11)
2022 (11)
2021 (10)
2025 (9)
2019 (9)
2023 (6)
2017 (6)
2015 (4)
2016 (3)
2018 (2)
2014 (1)

Lab affiliation

Instituto de Investigaciones Sanitarias de Santiago de Compostela (5)
Department of Convergence Medicine, Convergence Medicine Research Center/Biomedical Research Center, Asan Medical Center, Asan Institute for Life Sciences, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul 05505, Republic of Korea. (4)
Department of Biology, Institute of Molecular Systems Biology, ETH Zurich, Zurich, Switzerland (3)
Department of Orthopedic Surgery, Sir Run Run Shaw Hospital, Medical College of Zhejiang University, Hangzhou City, China. (3)
ETH Zurich (3)
Parasitology Laboratory, Institute of Natural Resources and Agrobiology (IRNASA, CSIC). Cordel de Merinas, 40-52, 37008 Salamanca, Spain. (3)
Yale Cancer Biology Institute (3)
1 Department of Biology, Institute of Molecular Systems Biology, ETH Zurich, Auguste-Piccard-Hof 1, 8093 Zurich, Switzerland 2 Faculty of Science, University of Zurich, Zurich, Switzerland (2)
Boston University Medical Campus 670 Albany St., Rm. 509 Boston, MA 02118 USA (2)
Burns and Trauma Research,School of Biomedical Sciences, Queensland University of Technology (2)
Department of Biology, Institute of Molecular Systems Biology, ETH, Zurich, Switzerland (2)
Department of Fisheries, College of Animal Science and Technology, Hunan agriculture university (2)
Department of Pathology, School of Basic Medicinel, Tongji Medical Collegells, Huazhong University of Science and Technology, Wuhan, Hubei 430030, China (2)
ETH Zurich, Switzerland (2)
Hubei Normal University (2)
Laboratory of Biotechnology of Reproduction, Institute for Animal Science and Technology (ICTA), Universitat Politècnica de València, 46022 Valencia, Spain (2)
Lee Kong Chian School of Medicine, School of Biological Sciences, Nanyang Technological University, Singapore (2)
Prometabio Research Institute, prometabio co., ltd. (2)
Research Officer|Proteomics and Small Molecule Mass Spectrometry Laboratory | Central Analytical Research Facility (CARF)| Queensland University of Technology | Address: Level 6, P Block, Gardens Point Campus, 2 George St Brisbane QLD 4000 (2)
Yale Cancer Biology Institute, Department of Pharmacology, Yale University School of Medicine (2)
Yale University School of Medicine (2)
1, Department of Biology, Institute of Molecular Systems Biology, ETH, Zurich, Switzerland 2, Faculty of Science, University of Zurich, Zurich, Switzerland (1)
Analytical Science & Technology (Protein Analytics), Bioprocessing Technology Institute (BTI), Agency for Science, Technology and Research (A*STAR), 20 Biopolis Way, Centros, Singapore 138668 (1)
Animal Cell Technology Unit, iBET - Instituto de Biologia Experimental e Tecnológica (1)
Applied Science and Technology Department–BioSolar Lab, Politecnico di Torino,Italy (1)
Assoc. Prof. at Novo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen, Copenhagen, Denmark (1)
Beijing Institute of Hepatology, Beijing You’an Hospital, Capital Medical University, Beijing 100069, China (1)
Beijing University of Chemical Technology (1)
Biognosys AG (1)
Biognosys AG, Schlieren, Switzerland (1)

Previous page
1 / 31
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 31
Next page

Sort by:

Relevance

Page size

Bridging Targeted (Zeno MRM-HR) and Untargeted (SWATH) LC–HRMS in a Single Run for Sensitive Exposomics

Traditionally, chemical exposure has been assessed by low-resolution mass spectrometry via targeted approaches due to the typically extremely low concentration of such compounds in biological samples. Nevertheless, untargeted approaches are now becoming a promising tool for a broader investigatio...

2025-08-28 | MTBLS10565 | MetaboLights

SWATH-MS identification of CXCL7, LBP, TGFβ1 and PDGFRβ as novel biomarkers in human systemic mastocytosis.

We carried out a novel clinical biomarker investigation of the blood of systemic mastocytosis patients versus healthy controls; utilizing a new and emerging technology platform Sequential Window Acquisition of all Theoretical fragment-ion spectra mass spectrometry (SWATH-MS). This is the first use ...

ORGANISM(S): Homo sapiens (Human)

2022-05-20 | PXD030947 | Pride

A comprehensive CHO SWATH-MS spectral library for accurate quantitative profiling of 10k proteins

A comprehensive Chinese hamster ovary (CHO)-cell specific spectral library, containing extensive information of high-quality spectral ions covering more than 10k CHO cell proteins, was constructed to provide confident and reproducible protein identification and quantification in data-independent SWA...

ORGANISM(S): Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus)

2020-07-20 | PXD016047 | Pride

Tripletof 6600 Swath-ms Chinese hamster ovary cells Lc-ms/ms

Circulating proteins detected by SWATH-MS in metastatic NSCLC patients treated with immunotherapy.

Immunotherapy has improved survival rates in NSCLC patients, but identifying those who will respond to treatment remains a challenge. We performed a differential proteomic quantitative analysis based on SWATH–MS technology to analyse the proteome in blood samples collected from patients with advance...

ORGANISM(S): Homo sapiens (Human)

2025-02-18 | PXD042091 | Pride

Liquid biopsy. Lung cancer Immunotherapy Nsclc Swath-ms

SWATH-MS based quantitative proteomics analysis reveals that curcumin alters the metabolic enzyme profile of CML cells by affecting the activity of miR-22/IPO7/HIF-1α axis.

Chronic myelogenous leukemia (CML) is a myeloproliferative disorder caused by expression of the chimeric BCR-ABL tyrosine kinase oncogene, resulting from the t(9;22) chromosomal translocation. Imatinib (gleevec, STI-571) is a selective inhibitor of Bcr-Abl activity highly effective in the treatment...

ORGANISM(S): Homo sapiens (Human)

2018-07-30 | PXD007771 | Pride

Swath-ms cml cells curcumin

Data-independent acquisition-based SWATH-MS for quantitative proteomics: a tutorial.

Not available

S-EPMC6088389 | biostudies-literature

Human colorectal cancer cell lines with manipulated AGR2 expression SWATH MS

SWATH MS analysis of colorectal adenocarcinoma derived paired cellular model, namely SW480 derived from a primary tumour and SW620 derived from the tumour´s lymph node metastasis. The whole proteome spectra were analysed to assess the changes caused by the manipulation of AGR2 expression. AGR2, a pr...

ORGANISM(S): Homo sapiens (Human)

2025-04-23 | PXD053085 | Pride

Sw480 Colorectal adenocarcinoma Sw620 Agr2 Swath ms

Label-free Quantitative Analysis of Protein Expression Alterations in miR-26a-Knockout HeLa Cells using SWATH-MS Technology.

Not available

S-EPMC6362012 | biostudies-literature

Zebrafish SWATH-MS spectral library to quantify 10,000 proteins

Sequential window acquisition of all theoretical mass spectra (SWATH-MS) requires a spectral library to extract quantitative measurements from the mass spectrometry data acquired in data-independent acquisition mode (DIA). Large combined spectral libraries containing SWATH assays have been generated...

ORGANISM(S): Danio rerio (Zebrafish) (Brachydanio rerio)

2018-12-18 | PXD010876 | Pride

Eye Intestine Heart Brain Liver Zebrafish Ovaries Spleen Testes Muscle

Comparison of Capillary and Schirmer Strip Tear Fluid Sampling Methods Using SWATH-MS Proteomics Approach.

Not available

S-EPMC7351636 | biostudies-literature

Previous page
1 / 31
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 31
Next page

Sort by:

Relevance

Page size

303 Results

Show results for

Organisms

Repository

Tissue

Disease

Technology Type

Instrument Platform

Publication Date

CHEBI ID

Metabolite Name

Release Date

Lab affiliation

OmicsDI is part of the ELIXIR infrastructure

Tweets